EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents

Simona-Alina Abu-Awwad iD, Ahmed Abu-Awwad iD, Madalina-Ianca Suba iD, Voichita Elena Lazureanu, Andrei-Daniel Bolovan, Ovidiu Rosca iD, Mirela-Mădălina Turaiche, Adela-Teodora Benea, Bogdan Hogea iD

Infectious Disease Reports · 24.04.2024 · 16 (3) · 423-434

DOI: 10.3390/idr16030031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 24.04.2024. Verfasst von Simona-Alina Abu-Awwad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ist Clinic of Obstetrics and Gynecology, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babes” University of Medicine and Pharmacy Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Since the advent of zidovudine in 1987, antiretroviral therapy has undergone significant evolution, marked by the introduction of 34 antiretroviral drugs and 24 fixed-dose combinations. Despite these advances, hepatotoxicity remains a formidable challenge, influencing morbidity, mortality, and treatment adherence in HIV-infected patients. This study aims to compare the hepatotoxic effects of latest-generation antiretroviral medications with those of older-generation therapies, assessing their long-term impact on liver health in HIV patients. (2)

Methods

This retrospective study analyzed data from 304 HIV patients treated with either latest-generation or older-generation antiretroviral drugs over four years. Patients were monitored for hepatotoxicity through liver function tests at diagnosis, six months, and one-year post-treatment initiation. (3)

Results

Initial and six-month liver function tests showed no significant differences between the two groups. However, at one-year post-treatment, patients on latest-generation antiretrovirals exhibited significant improvements in ALT, AST, and ALP levels, suggesting a better safety profile regarding hepatotoxicity. Additionally, a significantly lower incidence of splenomegaly was observed in patients treated with newer medications. (4)

Conclusions

The findings suggest that the latest-generation antiretroviral medications may offer a safer profile in terms of hepatotoxicity compared to older therapies, with potential benefits for long-term liver health. This study underscores the importance of continuous monitoring and further research to optimize ART strategies, ensuring improved patient outcomes and quality of life for individuals living with HIV.

Schlagwörter

Stichwörter der Autor:innen

HIVantiretroviral therapyhepatic metabolismlatest-generation ARV therapiesliver functionliver metabolic healthold-generation ARV therapies

Autor:innen und Institutionen

  • Ist Clinic of Obstetrics and Gynecology, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Department XV-Discipline of Orthopedics-Traumatology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Research Center University Professor Doctor Teodor Sora, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.
  • Dr. Victor Babes, Infectious Diseases and Pneumophthisiology Hospital Timisoara, 300310 Timisoara, Romania.

ORCID-Profile: Simona-Alina Abu-Awwad, Ahmed Abu-Awwad, Madalina-Ianca Suba, Ovidiu Rosca, Bogdan Hogea

Förderung

  • “Victor Babes” University of Medicine and Pharmacy Timisoara

Zitieren

APA

Abu-Awwad, S. A., Abu-Awwad, A., Suba, M. I., Lazureanu, V. E., Bolovan, A. D., Rosca, O., Turaiche, M. M., Benea, A. T., & Hogea, B. (2024). Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents. Infectious Disease Reports, 16(3), 423-434. https://doi.org/10.3390/idr16030031

Vancouver

Abu-Awwad SA, Abu-Awwad A, Suba MI, Lazureanu VE, Bolovan AD, Rosca O, et al. Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents. Infectious Disease Reports. 2024;16(3):423-434. doi:10.3390/idr16030031

BibTeX
@article{AbuAwwad2024,
  author = {Abu-Awwad, Simona-Alina and Abu-Awwad, Ahmed and Suba, Madalina-Ianca and Lazureanu, Voichita Elena and Bolovan, Andrei-Daniel and Rosca, Ovidiu and Turaiche, Mirela-Mădălina and Benea, Adela-Teodora and Hogea, Bogdan},
  title = {Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents},
  journal = {Infectious Disease Reports},
  year = {2024},
  volume = {16},
  number = {3},
  pages = {423--434},
  doi = {10.3390/idr16030031}
}
Kostenlos starten →